This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Sep 13;296(10):1229; author reply 1230.

doi: 10.1001/jama.296.10.1229-a.

Antiarrhythmic therapy for prevention of implantable cardioverter defibrillator shocks

PMID: 16968841
DOI: 10.1001/jama.296.10.1229-a

Comment

Antiarrhythmic therapy for prevention of implantable cardioverter defibrillator shocks

Abdul Wase. JAMA. 2006.

. 2006 Sep 13;296(10):1229; author reply 1230.

doi: 10.1001/jama.296.10.1229-a.

Author

PMID: 16968841
DOI: 10.1001/jama.296.10.1229-a

No abstract available

PubMed Disclaimer

Comment on

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Connolly SJ, et al. JAMA. 2006 Jan 11;295(2):165-71. doi: 10.1001/jama.295.2.165. JAMA. 2006. PMID: 16403928 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information